Q/C Technologies, Inc. (QCLS)
1.79
-0.09
(-4.79%)
USD |
NASDAQ |
Sep 04, 16:00
1.78
-0.01
(-0.56%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 14.66M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -50.42% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | 0.9193 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.0195 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.99% |
Profile
| Q/C Technologies, Inc. engages in the provision of energy-efficient blockchain and cryptocurrency infrastructure through quantum-class laser-based computing. It operates through the Pharmaceuticals and Computing Technology segments. The Pharmaceuticals segment operates in the clinical-stage pharmaceutical space and is specifically focused on isomyosamine (formerly MYMD-1). The Computing Technology segment is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications and beyond. The company was founded in 1989 and is headquartered in New York, NY. |
| URL | http://www.qctechnologies.com |
| Investor Relations URL | https://ir.tnfpharma.com/ |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Nov. 14, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Q/C Technologies, Inc. engages in the provision of energy-efficient blockchain and cryptocurrency infrastructure through quantum-class laser-based computing. It operates through the Pharmaceuticals and Computing Technology segments. The Pharmaceuticals segment operates in the clinical-stage pharmaceutical space and is specifically focused on isomyosamine (formerly MYMD-1). The Computing Technology segment is involved in the development and eventual application of quantum computing technology, both for cryptocurrency applications and beyond. The company was founded in 1989 and is headquartered in New York, NY. |
| URL | http://www.qctechnologies.com |
| Investor Relations URL | https://ir.tnfpharma.com/ |
| HQ State/Province | New York |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | N/A |
| Last Earnings Release | Nov. 14, 2024 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |